Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 51, 2021 - Issue 10
Submit an article Journal homepage
177
Views
2
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

The in vivo disposition of subcutaneous injected 14C-razuprotafib (14C-AKB-9778), a sulphamic acid phosphatase inhibitor, in nonclinical species and human

Brandi Lynn Soldoa Aerpio Pharmaceuticals, Cincinnati, OH, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7469-4645
ORCID Icon,
Patrick Camillerib Bio-Chemical Solutions, Stevenage, UK
,
Akshay Bucha Aerpio Pharmaceuticals, Cincinnati, OH, USA
&
John Janusza Aerpio Pharmaceuticals, Cincinnati, OH, USA
Pages 1132-1145 | Received 22 Jun 2021, Accepted 21 Aug 2021, Published online: 01 Sep 2021

References

  • Camilleri P, Soldo B, Buch A, Janusz J. 2021. Oxidative metabolism of razuprotafib, a sulfamic acid phosp hatase inhibitor, in human microsomes and recombinant human CYP2C8 enzyme. Xenobiotica:1–12. DOI:https://doi.org/10.1080/00498254.2021.1969482
  • Campochiaro P, Peters K. 2016. Targeting tie2 for treatment of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 16(12):126.
  • Campochiaro PA, Sophie R, Tolentino M, Miller DM, Browning D, Boyer DS, Heier JS, Gambino L, Withers B, Brigell M, et al. 2015. Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2. Ophthalmology. 122(3):545–554.
  • Collings AJ. 1989. Metabolism of cyclamate and its conversion to cyclohexylamine. Diabetes Care. 12(1):50–55.
  • Donat F, Duret JP, Santoni A, Cariou R, Necciari J, Magnani H, de Grief R. 2002. The pharmacokinetics of fondaparinux sodium in healthy volunteers. Clin Pharmacokinet. 41(Supp2):1–9.
  • Farid N, Kurihara A, Wrighton SA. 2010. Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans. J Clin Pharmacol. 50(2):126–142.
  • Farid NA, Smith RL, Gillespie TA, Rash TJ, Blair PE, Kurihara A, Goldberg MJ. 2007. The disposition of prasugrel, a novel thienopyridine, in humans. Drug Metab Dispos. 35(7):1096–1104.
  • Hamilton RA, Garnett WR, Kline BJ. 1981. Determination of mean valproic acid serum level by assay of a single pooled sample. Clin Pharmacol Ther. 29(3):408–413.
  • Kim M, Jeong ES, Park J, Lee S, Ghim JL, Choi C, Shin J, Kim D. 2014. Multiple cytochrome P450 isoforms are involved in the generation of a pharmacologically active thiol metabolite, whereas paraoxonase 1 and carboxylesterase 1 catalyze the formation of a thiol metabolite isomer from ticlopidines. Drug Metab Dispos. 42(1):141–152.
  • Liu C, Chen Z, Zhong K, Li L, Zhu W, Chen X, Zhong G. 2015. Human liver cytochrome P450 enzymes and microsomal thiol methyltransferase are involved in the stereoselective formation and methylation of the pharmacologically active metabolite of clopidogrel. Drug Metab Dispos. 43(10):1632–1641.
  • NCT03197870 2021. The TIME-2b study: a study of AKB-9778, a novel tie2 activator, in patients with non-proliferative diabetic retinopathy (NPDR) (TIME-2b). [accessed 2021 Aug 24]. https://clinicaltrials.gov/ct2/show/NCT03197870.
  • NCT04405245 2021. Study to assess the efficacy, safety and tolerability of AKB-9778 ophthalmic solution as an adjunct to latanoprost in patients with ocular hypertension or open angle glaucoma. [accessed 2021 Aug 24]. https://clinicaltrials.gov/ct2/show/NCT04405245.
  • Parkinson A, Mudra DR, Johnson C, Dwyer A, Carroll KM. 2004. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol. 199(3):193–209.
  • Pearce RE, McIntyre CJ, Madan A, Sanzgiri U, Draper AJ, Bullock PL, Cook DC, Burton LA, Latham J, Nevins C, et al. 1996. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. Arch Biochem Biophys. 331(2):145–169.
  • Peters KG, Kontos CD, Lin PC, Wong AL, Rao P, Huang L, Dewhirst MW, Sankar S. 2004. Functional significance of Tie2 signaling in the adult vasculature. Recent Prog Horm Res. 59:51–71.
  • Saharinen P, Eklund L, Alitalo K. 2017. Therapeutic targeting of the angiopoietin-TIE pathway. Nat Rev Drug Discov. 16(9):635–661.
  • Shen J, Frye M, Lee BL, Reinardy JL, McClung JM, Ding K, Kojima M, Xia H, Seidel C, Lima e Silva R, et al. 2014. Targeting VE-PTP activates TIE2 and stabilises the ocular vasculature. J Clin Invest. 124(10):4564–4575.
  • Swabb EA, Singhvi SM, Leitz MA, Frantz M, Sugerman AA. 1983. Metabolism and pharmacokinetics of aztreonam in healthy subjects. Antimicrob Agents and Chemother. 24(2):394–400.
  • Thomas M, August HG. 2009. The role of the Angiopoietins in vascular morphogenesis. Angiogenesis. 12(2):125–137.
  • Vestweber D. 2021. Vascular endothelial protein tyrosine phosphatase regulates endothelial Function. Physiology. 36(2):84–93.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.